VIEMED HEALTHCARE, INC.

VMD· Nasdaq· Services-Misc Health & Allied Services, NEC

Market cap
–
P/FCF
–
EV/Sales
–
FCF margin
4.4%
ROIC, 5 yr avg
10.1%
Revenue, 5 yr CAGR
+15.5%
We record prices for the companies we cover; VMD is not one of them yet.

Company statistics

From the 10-Ks, computed in code · point at a figure for its formula

Profile · FY2025

Market cap
–
Enterprise value
–
Diluted shares
40.8M
Revenue
$270.3M
Free cash flow
$11.9M
Owner earnings
$2.8M

Valuation · FY2025

P/E
–
P/FCF
–
P/Owner earnings
–
EV/Sales
–
EV/FCF
–
P/B
–

Margins · FY2025

Gross
57.5%
Operating
8.5%
Net
5.5%
Free cash flow
4.4%
Owner earnings
1.0%
Stock pay
3.4%

Returns

ROIC, FY2025
11.5%
ROIC, 5 yr avg
10.1%
ROE, FY2025
10.6%
ROE, 5 yr avg
8.8%

Growth (CAGR)

Revenue, 3 yr
24.9%
Revenue, 5 yr
15.5%
Revenue, 7 yr
22.7%
Diluted EPS, 3 yr
32.2%
Diluted EPS, 5 yr
-13.9%
Diluted EPS, 7 yr
6.4%
Free cash flow, 3 yr
35.0%
Free cash flow, 5 yr
-11.6%
Free cash flow, 7 yr
-4.3%

Financial health · FY2025

Cash and investments
$13.5M
Total debt
$12.4M
Net cash
$1.1M
Debt/Equity
0.1x
Debt/FCF
1.0x

Shareholder returns · FY2025

Dividend yield
–
Payout ratio
–
Buyback yield
–
Shareholder yield
–
Share count, 5 yr
0.1%

Financials: ten years from the 10-Ks

Reported numbers open their filing · computed ones show the formula · ˢ split-adjusted

Revenue

$270.3M

+22.7% a year over 7 years

FY2018: Revenue $64.5MFY2019: Revenue $80.3MFY2020: Revenue $131.3MFY2021: Revenue $117.1MFY2022: Revenue $138.8MFY2023: Revenue $183.0MFY2024: Revenue $224.3MFY2025: Revenue $270.3M
FY2018FY2025

Margins

Gross57.5%Operating8.5%Net5.5%

FY2025

FY2018: Gross 74.1%, Operating 15.6%, Net 14.7%FY2019: Gross 69.8%, Operating 11.0%, Net 10.6%FY2020: Gross 61.0%, Operating 20.4%, Net 24.0%FY2021: Gross 62.7%, Operating 9.9%, Net 7.8%FY2022: Gross 61.0%, Operating 5.9%, Net 4.5%FY2023: Gross 61.6%, Operating 7.8%, Net 5.6%FY2024: Gross 59.4%, Operating 8.0%, Net 5.0%FY2025: Gross 57.5%, Operating 8.5%, Net 5.5%
FY2018FY2025

Free cash flow and owner earnings

Free cash flow$11.9MOwner earnings$2.8M

Free cash flow -4.3% a year

FY2018: Free cash flow $16.3M, Owner earnings $13.6MFY2019: Free cash flow $5.7M, Owner earnings $1.8MFY2020: Free cash flow $22.1M, Owner earnings $17.2MFY2021: Free cash flow $2.8M, Owner earnings -$2.4MFY2022: Free cash flow $4.8M, Owner earnings -$352.0KFY2023: Free cash flow $19.1M, Owner earnings $13.3MFY2024: Free cash flow $1.3M, Owner earnings -$5.0MFY2025: Free cash flow $11.9M, Owner earnings $2.8M
FY2018FY2025

Diluted shares

40.8M

+2.9% over 7 years, net dilution

FY2018: Diluted shares 39.7MFY2019: Diluted shares 39.7MFY2020: Diluted shares 40.5MFY2021: Diluted shares 40.7MFY2022: Diluted shares 39.8MFY2023: Diluted shares 40.4MFY2024: Diluted shares 40.8MFY2025: Diluted shares 40.8M
FY2018FY2025

Return on invested capital

11.5%

FY2025

FY2018: ROIC 44.6%FY2019: ROIC 21.6%FY2020: ROIC –FY2021: ROIC 11.7%FY2022: ROIC 7.1%FY2023: ROIC 9.4%FY2024: ROIC 10.7%FY2025: ROIC 11.5%
FY2018FY2025

Net cash

$1.1M

$1.1M more cash than debt

FY2018: Net cash $10.4MFY2019: Net cash $4.0MFY2020: Net cash $23.3MFY2021: Net cash $22.6MFY2022: Net cash $16.9MFY2023: Net cash $5.8MFY2024: Net cash $13.5MFY2025: Net cash $1.1M
FY2018FY2025

Every figure, year by year

Fiscal yearFY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
The business
Revenue$64.5M$80.3M$131.3M$117.1M$138.8M$183.0M$224.3M$270.3M
Revenue growth–24.5%63.6%-10.8%18.6%31.8%22.5%20.5%
Gross margin74.1%69.8%61.0%62.7%61.0%61.6%59.4%57.5%
Operating margin15.6%11.0%20.4%9.9%5.9%7.8%8.0%8.5%
Net income$9.5M$8.5M$31.5M$9.1M$6.2M$10.2M$11.3M$14.9M
Net margin14.7%10.6%24.0%7.8%4.5%5.6%5.0%5.5%
Diluted EPS$0.24$0.21$0.78$0.22$0.16$0.25$0.28$0.37
Return on invested capital?44.6%21.6%–11.7%7.1%9.4%10.7%11.5%
Cash
Operating cash flow$22.4M$19.1M$35.1M$22.5M$27.7M$45.2M$39.1M$51.9M
Capital expenditure$6.1M$13.4M$13.0M$19.7M$22.9M$26.1M$37.8M$40.0M
Free cash flow$16.3M$5.7M$22.1M$2.8M$4.8M$19.1M$1.3M$11.9M
Stock-based compensation$2.7M$3.9M$4.9M$5.2M$5.2M$5.8M$6.3M$9.1M
Owner earnings?$13.6M$1.8M$17.2M-$2.4M-$352.0K$13.3M-$5.0M$2.8M
Free cash flow per share$0.41$0.14$0.54$0.07$0.12$0.47$0.03$0.29
Capital allocation
Dividends paid––––––––
Share repurchases$1.6M$1.5M$0$0$9.6M$0$0$13.2M
Diluted shares39.7M39.7M40.5M40.7M39.8M40.4M40.8M40.8M
Share count change?–0.2%2.0%0.4%-2.1%1.4%1.1%0.0%
Balance sheet
Cash and equivalents$10.4M$13.4M$31.0M$28.4M$16.9M$12.8M$17.5M$13.5M
Short-term investments––––––––
Total debt$0$9.4M$7.6M$5.8M$0$7.1M$4.0M$12.4M
Net debt-$10.4M-$4.0M-$23.3M-$22.6M-$16.9M-$5.8M-$13.5M-$1.1M
Shareholders' equity$32.6M$43.7M$81.7M$94.8M$97.1M$113.9M$131.4M$141.5M

Latest filings

All on EDGAR
2026-08-0310-QQuarterly report
2026-08-038-KEarnings release
2026-05-058-KEarnings release
2026-05-0510-QQuarterly report
2026-04-22DEF 14AProxy statement
2026-03-048-KEarnings release
2026-03-0410-KAnnual report
2025-11-058-KEarnings release
2025-11-0510-QQuarterly report
2025-08-0610-QQuarterly report

More from our coverage

All coverage